Hiroaki Wakimoto

39PUBLICATIONS
182CO-AUTHORS
Molecular targetsGene and molecular therapyHaematological tumoursGenomics and transcriptomicsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Oct 02, 2026
Combination treatment with RAF/MEK inhibitor avutometinib and FAK inhibitor defactinib in preclinical models of meningioma.

|Jun 25, 2026
Triple-Survival Stereotactic Brain Surgeries for the Intracranial Injections of Glioblastoma Stem-like Cells and Oncolytic Herpes Simplex Viruses.

|Jun 08, 2026
Combining the KRASG12C inhibitor adagrasib with anti-PD-1 immunotherapy improves overall survival and prevents recurrence in preclinical models of brain metastasis.

|Jun 03, 2026
Acquired genetic and cell-state changes in IDH-mutant glioma progression.

|Mar 30, 2026
Effects of short- and long-term mutant IDH1 inhibition on radiosensitivity across genetically diverse patient-derived IDH1-mutant glioma cells.

Yosuke Kitagawa, Logan D Muzyka, Ami Kobayashi

|Mar 18, 2026
A blueprint for local and distal invasion programs in glioblastoma.

Rony Chanoch-Myers, Toshiro Hara, Alissa C Greenwald

Pageof 7

Frequent Collaborators

6 joint publications

Samuel D Rabkin

5 joint publications

Khalid Shah

4 joint publications

Clemens Reinshagen

4 joint publications

Deepak Bhere